{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T10:11:25Z","timestamp":1745057485197,"version":"3.40.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12185-022-03449-y","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T04:04:47Z","timestamp":1662437087000},"page":"137-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Spontaneous regression of dasatinib-related primary effusion lymphoma-like lymphoma"],"prefix":"10.1007","volume":"117","author":[{"given":"Kenta","family":"Hayashino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3414-1373","authenticated-orcid":false,"given":"Yusuke","family":"Meguri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryouya","family":"Yukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Komura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikamasa","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakako","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Imajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"3449_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-230X(01)80014-2","volume":"80","author":"G Gaidano","year":"2001","unstructured":"Gaidano G, Carbone A. Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities. Adv Cancer Res. 2001;80:115\u201346.","journal-title":"Adv Cancer Res"},{"key":"3449_CR2","first-page":"271","volume":"30","author":"X Yiakoumis","year":"2010","unstructured":"Yiakoumis X, Pangalis GA, Kyrtsonis MC, Vassilakopoulos TP, Kontopidou FN, Kalpadakis C, et al. Primary effusion lymphoma in two HIV-negative patients successfully treated with pleurodesis as first-line therapy. Anticancer Res. 2010;30:271\u20136.","journal-title":"Anticancer Res"},{"key":"3449_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3748\/wjg.v20.i3.857","volume":"20","author":"E Nussinson","year":"2014","unstructured":"Nussinson E, Shibli F, Shahbari A, Rock W, Elias M, Elmalah I. Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease. World J Gastroenterol. 2014;20:857\u201362.","journal-title":"World J Gastroenterol"},{"key":"3449_CR4","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1182\/bloodadvances.2020002293","volume":"4","author":"D Kaji","year":"2020","unstructured":"Kaji D, Ota Y, Sato Y, Nagafuji K, Ueda Y, Okamoto M, et al. Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis. Blood Adv. 2020;4:4442\u201350.","journal-title":"Blood Adv"},{"key":"3449_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/PAS.0b013e318267fabc","volume":"37","author":"S Alexanian","year":"2013","unstructured":"Alexanian S, Said J, Lones M, Pullarkat ST. KSHV\/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states. Am J Surg Pathol. 2013;37:241\u20139.","journal-title":"Am J Surg Pathol"},{"key":"3449_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1309\/AJCPHZ3CHO4HUWET","volume":"140","author":"W Wu","year":"2013","unstructured":"Wu W, Youm W, Rezk SA, Zhao X. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma report of a rare case and review of 54 cases in the literature. Am J Clin Pathol. 2013;140:258\u201373.","journal-title":"Am J Clin Pathol"},{"key":"3449_CR7","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1080\/1042819031000104015","volume":"44","author":"GP Paner","year":"2003","unstructured":"Paner GP, Jensen J, Foreman KE, Reyes CV. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Leuk Lymphoma. 2003;44:1811\u20134.","journal-title":"Leuk Lymphoma"},{"key":"3449_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1182\/blood-2016-02-700153","volume":"128","author":"P Rousselot","year":"2016","unstructured":"Rousselot P, Coud\u00e9 MM, Gokbuget N, Passerini CG, Hayette S, Cayuela JM, et al. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive all. Blood. 2016;128:774\u201382.","journal-title":"Blood"},{"key":"3449_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","volume":"34","author":"JE Cortes","year":"2016","unstructured":"Cortes JE, Saglio G, Kantarjian HM, Baccarani M, Mayer J, Boqu\u00e9 C, et al. Final 5-year study results of DASISION: the dasatinib versus imatinib study in treatment-na\u00efve chronic myeloid leukemia patients trial. J Clin Oncol. 2016;34:2333\u201340.","journal-title":"J Clin Oncol"},{"key":"3449_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-2-46","volume":"2","author":"D Masiello","year":"2009","unstructured":"Masiello D, Gorospe G, Yang AS. The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib. J Hematol Oncol. 2009;2:1\u20136.","journal-title":"J Hematol Oncol"},{"key":"3449_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3324\/haematol.2018.188987","volume":"104","author":"TP Hughes","year":"2019","unstructured":"Hughes TP, Laneuville P, Rousselot P, Snyder DS, Rea D, Shah NP, et al. Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for philadelphia chromosome-positive leukemia. Haematologica. 2019;104:93\u2013101.","journal-title":"Haematologica"},{"key":"3449_CR12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/j.1365-2702.2009.03167.x","volume":"19","author":"SM Tinsley","year":"2010","unstructured":"Tinsley SM. Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia. J Clin Nurs. 2010;19:1207\u201318.","journal-title":"J Clin Nurs"},{"key":"3449_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3960\/jslrt.17020","volume":"57","author":"M Kojima","year":"2017","unstructured":"Kojima M, Nakamura N, Amaki J, Numata H, Miyaoka M, Motoori T, et al. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma following tyrosine kinase inhibitor treatment for chronic myelogenous leukemia. J Clin Exp Hematop. 2017;57:69\u201373.","journal-title":"J Clin Exp Hematop"},{"key":"3449_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/cyt.12890","volume":"31","author":"D Miyagi","year":"2020","unstructured":"Miyagi D, Chen WY, Chen BJ, Su YZ, Kuo CC, Karube K, et al. Dasatinib-related effusion lymphoma in a patient treated for chronic myeloid leukaemia. Cytopathology. 2020;31:602\u20136.","journal-title":"Cytopathology"},{"key":"3449_CR15","first-page":"1","volume":"10","author":"S Fiori","year":"2021","unstructured":"Fiori S, Todisco E, Ramadan S, Gigli F, Falco P, Iurlo A, et al. HHV8-negative effusion-based large B cell lymphoma arising in chronic myeloid leukemia patients under dasatinib treatment: a report of two cases. Biology (Basel). 2021;10:1\u20137.","journal-title":"Biology (Basel)"},{"key":"3449_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12185-011-0906-8","volume":"94","author":"Y Terasaki","year":"2011","unstructured":"Terasaki Y, Yamamoto H, Kiyokawa H, Okumura H, Saito K, Ichinohasama R, et al. Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma. Int J Hematol. 2011;94:279\u201384.","journal-title":"Int J Hematol"},{"key":"3449_CR17","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.2169\/internalmedicine.47.1565","volume":"47","author":"Y Terasaki","year":"2008","unstructured":"Terasaki Y, Okumura H, Saito K, Sato Y, Yoshino T, Ichonohasama R, et al. HHV-8\/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. Intern Med. 2008;47:2175\u20138.","journal-title":"Intern Med"},{"key":"3449_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000350482","volume":"130","author":"SI Nakatsuka","year":"2013","unstructured":"Nakatsuka SI, Kimura H, Nagano T, Fujita M, Kanda T, Iwata T, et al. Self-limited effusion large B-cell lymphoma: two cases of effusion lymphoma maintaining remission after drainage alone. Acta Haematol. 2013;130:217\u201321.","journal-title":"Acta Haematol"},{"key":"3449_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-0463.2008.00005.x","volume":"117","author":"C Adiguzel","year":"2009","unstructured":"Adiguzel C, Bozkurt SU, Kaygusuz I, Uzay A, Tecimer T, Bayik M. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature. APMIS. 2009;117:222\u20139.","journal-title":"APMIS"},{"key":"3449_CR20","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1200\/JCO.2007.12.0329","volume":"25","author":"A Quint\u00e1s-Cardama","year":"2007","unstructured":"Quint\u00e1s-Cardama A, Kantarjian H, O\u2019Brien S, Borthakur G, Bruzzi J, Munden R, et al. Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure. J Clin Oncol. 2007;25:3908\u201314.","journal-title":"J Clin Oncol"},{"key":"3449_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/MAJ.0b013e3181ae9227","volume":"338","author":"M Goldblatt","year":"2009","unstructured":"Goldblatt M, Huggins JT, Doelken P, Gurung P, Sahn SA. Dasatinib-induced pleural effusions: a lymphatic network disorder? Am J Med Sci. 2009;338:414\u20137.","journal-title":"Am J Med Sci"},{"key":"3449_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/978-981-10-7230-7_17","volume":"1045","author":"T Kanda","year":"2018","unstructured":"Kanda T. EBV-encoded latent genes. Adv Exp Med Biol. 2018;1045:377\u201394.","journal-title":"Adv Exp Med Biol"},{"key":"3449_CR23","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1182\/blood-2007-04-084814","volume":"111","author":"AE Schade","year":"2008","unstructured":"Schade AE, Schieven GL, Townsend R, Jankowska AM, Susulic V, Zhang R, et al. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood. 2008;111:1366\u201377.","journal-title":"Blood"},{"key":"3449_CR24","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1158\/1078-0432.CCR-07-4393","volume":"14","author":"R Weichsel","year":"2008","unstructured":"Weichsel R, Dix C, Wooldridge L, Clement M, Fenton-May A, Sewell AK, et al. Profound inhibition of antigen-specific T-cell effector functions by dasatinib. Clin Cancer Res. 2008;14:2484\u201391.","journal-title":"Clin Cancer Res"},{"key":"3449_CR25","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jiac.2021.01.009","volume":"27","author":"A Yamada","year":"2021","unstructured":"Yamada A, Katagiri S, Moriyama M, Asano M, Suguro T, Yoshizawa S, et al. Epstein-Barr virus-associated post-transplant lymphoproliferative disease during dasatinib treatment occurred 10 years after umbilical cord blood transplantation. J Infect Chemother. 2021;27:1076\u20139.","journal-title":"J Infect Chemother"},{"key":"3449_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/bmt.2012.246","volume":"48","author":"M W\u00f6lfl","year":"2013","unstructured":"W\u00f6lfl M, Langhammer F, Wiegering V, Eyrich M, Schlegel PG. Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: Functional assays from whole blood as diagnostic clues. Bone Marrow Transplant. 2013;48:875\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"3449_CR27","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/leu.2009.46","volume":"23","author":"S Mustjoki","year":"2009","unstructured":"Mustjoki S, Ekblom M, Arstila TP, Dybedal I, Epling-Burnette PK, Guilhot F, et al. Clonal expansion of T\/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia. 2009;23:1398\u2013405.","journal-title":"Leukemia"},{"key":"3449_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1164\/rccm.200705-715CR","volume":"176","author":"A Bergeron","year":"2007","unstructured":"Bergeron A, R\u00e9a D, Levy V, Picard C, Meignin V, Tamburini J, et al. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: A case series. Am J Respir Crit Care Med. 2007;176:814\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"3449_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<287::AID-PATH932>3.0.CO;2-Q","volume":"183","author":"C Copie-Bergman","year":"1997","unstructured":"Copie-Bergman C, Niedobitek G, Mangham DC, Selves J, Baloch K, Diss TC, et al. Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation. J Pathol. 1997;183:287\u201392.","journal-title":"J Pathol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03449-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:53:51Z","timestamp":1744206831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03449-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3449"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03449-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"23 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that we have read the journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with these guidelines. This study was approved by the research ethics committee of Okayama City Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical publication statement"}}]}}